Nycomed To Beef Up Sales In China Through Buyout; Bets On India For Global API Supplies

MUMBAI - Having established itself firmly among the top 10 pharma companies in Russia, Zurich-headquartered Nycomed now plans to dig deeper into the fast-growing Chinese market through the acquisition of a sales and distribution team

More from Archive

More from Scrip